Common blood pressure drug could make cancer therapy far more powerful

Summary

Researchers demonstrated that the blood pressure medication telmisartan can enhance olaparib's cancer-fighting effectiveness, with the combination now in human clinical trials showing promising immune-boosting and anticancer effects in preclinical studies.